Search for: "Merck & Co., Inc. " Results 421 - 440 of 664
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Jan 2010, 3:00 am
Kappos (Patent Docs) US: Calculating PTA: PTO to offer ‘guidance for expediting requests’ (Patently-O) US: Senate votes against Bill allowing Americans to import prescription drugs (Pharmacapsules@Gowlings) US: Governors write President in support of 12-year data exclusivity period (Patent Docs) US: Obama moving to renegotiate biologics exclusivity period (Pharmacapsules@Gowlings) US: Law Professors Adelman and Holman contend that data exclusivity is secondary issue in follow-on… [read post]
25 Jan 2010, 8:07 pm
” In the context of Appellant’s specification and claims (which are part of the specification, see Merck & Co., Inc. v. [read post]
8 Jan 2010, 12:22 am
Supp. 2d 138, 141 (D.D.C. 2008) (citing Merck & Co. v. [read post]
5 Jan 2010, 11:44 pm
Basic Holding, Inc., 581 F.3d 1317, 1332 (Fed. [read post]
31 Dec 2009, 7:19 am
’s proposed $68 billion acquisition of Wyeth, and Schering-Plough Corporation was permitted to proceed with its proposed $41.1 billion acquisition of Merck & Co. [read post]
16 Dec 2009, 2:51 pm by Sheppard Mullin
The Federal Trade Commission announced in October 2009 that it will allow Schering-Plough Corporation's proposed $41.1 billion acquisition of Merck & Co., Inc. to proceed, subject to a consent order requiring the parties to each divest certain interests and assets in businesses where the FTC was concerned the transaction would have substantially reduced competition. [read post]
15 Dec 2009, 11:32 pm by Dr. Shezad Malik
Merck & Co. agreed to pay $4.85 billion to resolve more than 48,000 claims over the withdrawn painkiller. [read post]
4 Dec 2009, 2:22 am
The Supreme Court considers the ‘inquiry notice’ standard in federal securities fraud cases Simpson Thacher & Bartlett LLP "The Supreme Court heard oral arguments yesterday in Merck & Co, Inc. v. [read post]
3 Dec 2009, 10:16 pm
Supporters can click the Make it Happen link and send an email to the CEOs of Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer Inc. and Sequoia Pharmaceuticals Inc. [read post]
3 Dec 2009, 6:21 am
Below, Akin Gump's John Wittenzellner recaps Monday's oral argument in Merck & Co., Inc. v. [read post]
2 Dec 2009, 7:50 am
The WSJ Law Blog discusses the “interesting” argument made by Merck during oral argument on Monday in Merck & Co., Inc. v. [read post]